Skip to content

Comparative Analysis of NTG-Pd/Pa and Saline-Pd/Pa (CANS)

A Prospective, Multicenter Study: Comparative Analysis of NTG-Pd/Pa and Saline-Pd/Pa

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07195968
Enrollment
50
Registered
2025-09-29
Start date
2025-09-17
Completion date
2029-12-31
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary artery disease, Fractional flow reserve, NTG-Pd/Pa, Saline-Pd/Pa

Brief summary

The goal of this observational study is to compare the value of NTG-Pd/Pa and saline-Pd/Pa in participants with intermediate stenosis of the coronary artery. The main questions it aims to answer are: The numerical difference between NTG-Pd/Pa and saline-Pd/Pa To compare the diagnostic performance of NTG-Pd/Pa and saline-Pd/Pa in predicting the binary result of FFR assessment? Participants will undergo NTG-Pd/Pa, Saline-Pd/Pa, and FFR successively in the target vessel.

Detailed description

Fractional Flow Reserve (FFR) is the gold standard for determining the functional ischemia of coronary arteries with intermediate lesions. Both intracoronary nitroglycerine (NTG) administration and saline administration induce an acute drop in trans-lesional coronary pressure. Both pressure ratios correlate well with FFR values and can reliably predict positive results in FFR assessments. The aims of this study were 1. To evaluate the numerical difference between NTG-Pd/Pa and saline-Pd/Pa. 2. To test the repeatability of saline-Pd/Pa. 3. To compare the diagnostic performance of NTG-Pd/Pa and saline-Pd/Pa in predicting the binary result of FFR assessment. Participants will be enrolled prospectively from National Taiwan University Hospital Hsinchu Hospital, Miaoli General Hospital, and Taichung Veterans General Hospital. The coronary artery with intermediate stenosis will undergo NTG-Pd/Pa, saline-Pd/Pa, and FFR assessments sequentially. Saline-Pd/Pa will be tested repeatedly during the assessment.

Interventions

DIAGNOSTIC_TESTNTG-Pd/Pa measurement

The coronary artery with intermediate stenosis will sequentially undergo NTG-Pd/Pa, saline-Pd/Pa, and FFR assessments. Intracoronary NTG dosage will follow the protocol based on blood pressure.

DIAGNOSTIC_TESTSaline-Pd/Pa measurement

The coronary artery with intermediate stenosis will sequentially undergo NTG-Pd/Pa, saline-Pd/Pa, and FFR assessments. Ten millilitres of intracoronary saline will be given over five seconds.

Sponsors

Miaoli General Hospital, Ministry of Health and Welfare, Taiwan
CollaboratorUNKNOWN
Taichung Veterans General Hospital
CollaboratorOTHER
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants with coronary artery with 50-90% stenosis. * In participants who suffered from ST elevation myocardial infarction within 5 days, only the non-culprit vessel was eligible for coronary functional testing.

Exclusion criteria

* Systolic blood pressure is less than 90 mmHg for more than 5 minutes during examination. * Resting heart rate is less than 50 beats per minute. * Heart failure remains decompensated at the time of examination, such as inability to lie flat or cardiogenic shock. * Acute onset of asthma or chronic obstructive pulmonary disease.

Design outcomes

Primary

MeasureTime frameDescription
Absolute difference between NTG-Pd/Pa and Saline-Pd/Pa value3 minutesThe absolute difference was calculated as the Saline-Pd/Pa value minus the NTG-Pd/Pa value.

Secondary

MeasureTime frameDescription
Diagnostic performance of NTG-Pd/Pa and Saline-Pd/Pa4 minutesTo compare the diagnostic performance of NTG-Pd/Pa and saline-Pd/Pa in predicting the binary result of FFR≤0.80.
Repeatability of Saline-Pd/Pa2 minutesSaline-Pd/Pa will be measured at one-minute intervals, and the absolute differences between consecutive measurements will be analyzed.

Other

MeasureTime frameDescription
Target vessel failure3 yearsThe target vessel failure included target vessel myocardial infarction, target vessel restenosis or revascularization.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026